Form 4: SLAB CEO Robert Johnson Granted 25,218 RSUs
Insider Transaction Report
Silicon Laboratories Inc. CEO Robert Matthew Johnson received a grant of 25,218 restricted stock units, vesting over three years.
Summary
- Robert Matthew Johnson, President & CEO and Director of Silicon Laboratories Inc. (SLAB), was granted 25,218 shares of common stock in the form of Restricted Stock Units (RSUs).
- The transaction date for this acquisition was February 15, 2026.
- The RSUs were granted at a price of $0 per unit.
- Following this transaction, Robert Matthew Johnson directly beneficially owns 98,906 shares of common stock.
- One-third of the RSUs will vest on each of the first three anniversaries of the grant date.
- The RSUs will be settled according to the terms of the Issuer's 2009 Stock Incentive Plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with long-term shareholder value, without indicating any immediate operational or financial changes.
Positives
- The grant of Restricted Stock Units (RSUs) to the President & CEO aligns management's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
- The vesting schedule over three years encourages long-term commitment and performance from the executive.
Future Outlook
The grant of Restricted Stock Units (RSUs) to the CEO implies a future increase in his direct beneficial ownership of common stock as the units vest over the next three years, contingent on continued employment and company performance.
Industry Context
StockSavvy.ai notes that RSU grants are a standard component of executive compensation packages across the technology and semiconductor industries. This practice aims to incentivize long-term performance and align executive interests with shareholder value creation, a common strategy for retaining top talent in competitive sectors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Plan Utilization | The Restricted Stock Units (RSUs) were granted pursuant to the Issuer's 2009 Stock Incentive Plan (as amended from time to time), demonstrating the ongoing use of established corporate governance frameworks for executive compensation. | 02/15/2026 | Reinforces the company's commitment to its existing compensation policies and plans, providing a structured approach to incentivizing key executives. |
Related Party Transactions
- Robert Matthew Johnson, President & CEO and Director of Silicon Laboratories Inc., received a grant of 25,218 Restricted Stock Units (RSUs) from the company on February 15, 2026. This transaction is a direct compensation arrangement between an insider and the issuer.
Stakeholder Impact
- Shareholders: The RSU grant aligns the CEO's financial interests with long-term shareholder value, as the vesting is tied to the company's stock performance over three years.
- Employees: The compensation structure for the CEO may set a precedent or reflect the broader compensation philosophy within the company, potentially influencing employee morale and retention strategies.
Next Steps
- One-third of the granted RSUs will vest on the first anniversary of the grant date (February 15, 2027).
- One-third of the granted RSUs will vest on the second anniversary of the grant date (February 15, 2028).
- One-third of the granted RSUs will vest on the third anniversary of the grant date (February 15, 2029).
Key Dates
| Date | Description |
|---|---|
| 02/15/2026 | Date of RSU grant transaction to Robert Matthew Johnson. |
| 02/17/2026 | Date the Form 4 was signed by Saie-Yau Hui for Robert M. Johnson. |
Keywords
Silicon Laboratories, SLAB, Robert Johnson, Restricted Stock Units, RSU Grant, Insider Transaction, Executive Compensation, Stock Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.